Pemetrexed + Carboplatin + Olomorasib + PEMBROLIZUMAB + Cetuximab + CISPLATIN

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Pemetrexed + Carboplatin + Olomorasib + PEMBROLIZUMAB + Cetuximab + CISPLATIN
Treatment and conditionWhere it standsTrials
Pemetrexed + Carboplatin + Olomorasib + PEMBROLIZUMAB + Cetuximab + CISPLATIN for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1